Table 1.
Study period | ||||||
Hospital stay | Hospital discharge | Follow-up | Close-out | |||
TIME POINT | −1 to −7 days | 0 | M3 | M6 | M9 | M12 |
ENROLMENT | ||||||
Eligibility screen | X | |||||
Informed consent | X | |||||
INTERVENTIONS | ||||||
Medication reconciliation | X* | |||||
Medication review | X | |||||
Interview before discharge | X* | |||||
Providing educational brochures, discharge plan, medication plan | X* | |||||
Providing follow-up diary | X | |||||
Information sharing with healthcare professionals | X* | X* | X* | X* | X* | |
Telephone interviews | X* | X* | X* | |||
Final interview | X | |||||
ASSESSMENTS | ||||||
History, demographics | X | |||||
PRIMARY OUTCOME | ||||||
Medication possession ratio | X* | X* | X* | X | ||
Adherence scale | X | X | ||||
SECONDARY OUTCOMES | ||||||
Blood glucose control | X | X | ||||
Lipid control | X | X | ||||
Abdominal girth | X | X | ||||
Blood pressure | X | X | ||||
Quality of life (SF-36) | X | X | ||||
Belief/representation about the disease (Brief IPQR) | X | X | ||||
Knowledge about the disease and the treatments | X | X | ||||
Lifestyle | X | X | ||||
Number, type and severity of iatrogenic events | X | |||||
Proportion of patients having recurrent stroke or other major adverse cardiovascular event | X | |||||
Proportion of patients readmitted to hospital | X | |||||
Adherence to each secondary preventive drug | X | |||||
Patient satisfaction regarding treatments (SATMED-Q) | X | |||||
Patient satisfaction regarding the intervention programme | X* | |||||
Community pharmacist’s satisfaction regarding the intervention programme | X* | |||||
General practitioner’s satisfaction regarding the intervention programme | X* |
*Intervention group.
Brief IPQR, Brief Illness Perception Questionnaire; SATMED-Q, Treatment Satisfaction with Medicines Questionnaire; SF-36, Short Form 36 Health Survey questionnaire.